Hidradenitis Suppurativa Clinical Trials

Currently Enrolling

Phoenix, Arizona Clinical Trials:

• UCB Protocol HS0003: A Phase 3 Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa (BE HEARD I) (Clinical Trial Conducted in Phoenix, Arizona – 7th Street Location)  |  Learn More »  |  Request to Join This Study »

• Incyte Protocol INCB 54707-204: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa (Clinical Trial Conducted in Phoenix, Arizona – 7th Street Location)  |  Learn More »  |  Request to Join This Study »

Active / Not Enrolling

Phoenix, Arizona Clinical Trials:

• AbbVie Protocol M20-040: Evaluation of Upadacitinib in Adult Subjects with Hidradenitis Suppurativa. (Clinical Trial Conducted in Phoenix, Arizona) | Learn More »  |  No Longer Enrolling

View Other Clinical Trials

• Acne
• Actinic Keratoses
• Atopic Dermatitis (Eczema)
• Axillary Hyperhidrosis
• Bullous Pemphigoid
• Hidradenitis Suppurativa
• Lamellar Ichthyosis
• Organ Transplant Recipients
• Psoriasis
• Prurigo Nodularis
• Skin Cancer